Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» type 2 diabetes
type 2 diabetes
Boston's Intarcia now one step closer to upending type 2 diabetes market
Bizjournals.com
Mon, 06/8/15 - 11:23 am
Intarcia
type 2 diabetes
diabetes
ITCA 650
devices
Novo Nordisk type 2 diabetes combo drug tops Sanofi's Lantus -study
Yahoo/Reuters
Sun, 06/7/15 - 10:03 am
Novo Nordisk
type 2 diabetes
Sanofi
IDegLira
Lantus
FDA warns on newer class of type 2 diabetes drugs
Yahoo/Reuters
Sat, 05/16/15 - 02:04 pm
FDA
diabetes
type 2 diabetes
AstraZeneca
Farxiga
Eli Lilly
Jardiance
Boehringer Ingelheim
JNJ
Invokana
SGLT2 inhibitor
Isis Pharma Time Shifts Diabetes Drug Trial to Embellish Results
TheStreet.com
Tue, 02/3/15 - 10:45 am
Isis Pharmaceuticals
diabetes
type 2 diabetes
ISIS-PTP1B
FDA approves Boehringer-Lilly drug for type-2 diabetes patients
Yahoo/Reuters
Mon, 02/2/15 - 11:01 am
FDA
Eli Lilly
Boehringer Ingelheim
diabetes
type 2 diabetes
Glyxambi
FDA Label May Prevent Use of Metformin in Type 2 Diabetics
Drug Discovery and Development
Thu, 01/8/15 - 08:22 am
FDA
type 2 diabetes
metformin
Novo Nordisk's Victoza receives positive opinion for use in adults with type 2 diabetes
Reuters
Fri, 11/21/14 - 10:41 am
Novo Nordisk
type 2 diabetes
diabetes
Victoza
Boston Therapeutics Inc reports topline U.S.-based phase IIb study results of BTI-320 in patients with type 2 diabetes
Reuters
Thu, 10/9/14 - 10:54 am
Boston Therapeutics
type 2 diabetes
BTI-320
Vivus announces journal publication of Qsymia study results in type 2 diabetes
Seeking Alpha
Mon, 10/6/14 - 11:06 am
Vivus
Qsymia
type 2 diabetes
MannKind and Sanofi Complete Afrezza Collaboration Deal
Yahoo/Zacks
Sat, 09/27/14 - 10:11 am
MannKind
Sanofi
Afrezza
diabetes
type 2 diabetes
Who Will Win This $45 Billion Market?
Motley Fool
Sat, 06/21/14 - 11:45 am
Sanofi
Novo Nordisk
diabetes
type 1 diabetes
type 2 diabetes
Eli Lilly/ Boehringer Drug Under FDA Review
Yahoo/Zacks.com
Tue, 04/15/14 - 04:49 pm
FDA
Eli Lilly
Boehringer Ingelheim
Trajenta
empagliflozin
diabetes
type 2 diabetes
FDA approves Tanzeum to treat type 2 diabetes
Yahoo/Fly on the Wall
Tue, 04/15/14 - 10:34 am
FDA
Tanzeum
type 2 diabetes
diabetes
thyroid cancer
GSK
FDA staff review raises questions about MannKind diabetes device
Yahoo/Reuters
Sat, 03/29/14 - 09:13 am
MannKind
diabetes
type 2 diabetes
Type 2 Diabetes Gene Mutations Seen as Drugmaker Target
Bloomberg
Mon, 03/3/14 - 08:30 am
diabetes
type 2 diabetes
Pfizer
GlaxoSmithKline's Eperzan Gets Closer to Launch
Motley Fool
Sun, 01/26/14 - 10:53 am
GSK
Eperzan
diabetes
type 2 diabetes
Arena Eyes Additional Opportunity With Belviq
Seeking Alpha
Sat, 12/7/13 - 12:50 pm
Arena Pharmaceuticals
Belviq
smoking cessation
type 2 diabetes
Diabetes battle "being lost" as cases hit record 382 mln
Yahoo/Reuters
Thu, 11/14/13 - 10:36 am
diabetes
China
type 2 diabetes
Bristol-Myers: Interesting Investing Opportunity With Onglyza
Seeking Alpha
Sat, 09/28/13 - 12:15 pm
type 2 diabetes
Onglyza
diabetes
Bristol-Myers Squibb
AstraZeneca
Groundbreaking Diabetes Drug Headlines Approval Bonanza
Motley Fool
Sun, 09/22/13 - 11:25 am
diabetes
type 2 diabetes
type 1 diabetes
JNJ
inokana
Forxiga
AstraZeneca
Bristol-Myers Squibb
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
next ›
last »